PIRAMAL PHARMA: CO HAS RECEIVED SBTI APPROVAL FOR ITS COMMITMENT TO REDUCE SCOPE 1 AND 2 GHG EMISSIONS BY 42% AND SCOPE 3 BY 25% BY FY 2030 PIRAMAL PHARMA: CO HAS RECEIVED SBTI APPROVAL FOR ITS COMMITMENT TO REDUCE SCOPE 1 AND 2 GHG EMISSIONS BY 42% AND SCOPE 3 BY 25% BY FY 2030